Some of the side effects of semaglutide and tirzepatide include nausea, vomiting, diarrhea, abdominal pain, and constipation
To ensure that those most in need receive treatment even if cost constraints limit broader access, coverage should be allocated based on criteria such as severity of obesity, comorbidities, and age
Results of the LEADER and SUSTAIN-6 trials: cardiovascular outcomes with GLP-1 receptor agonists
But if CagriSema, their new next generation GLP-1 product shows the promise that they think it'll have, then that'll be a new patent cycle starting then, and then they'll develop the next generation, and it'll play out again just like Insulin
But for both Ozempic and retatrutide, the metabolic benefits extend well beyond the number on the scale